Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes.

Heijnen LA, Lambregts DM, Mondal D, Martens MH, Riedl RG, Beets GL, Beets-Tan RG.

Eur Radiol. 2013 Dec;23(12):3354-60. doi: 10.1007/s00330-013-2952-5.

PMID:
23821022
2.

Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study.

Lambregts DM, Maas M, Riedl RG, Bakers FC, Verwoerd JL, Kessels AG, Lammering G, Boetes C, Beets GL, Beets-Tan RG.

Eur Radiol. 2011 Feb;21(2):265-73. doi: 10.1007/s00330-010-1937-x.

3.

Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.

Seber T, Caglar E, Uylar T, Karaman N, Aktas E, Aribas BK.

Clin Imaging. 2015 Sep-Oct;39(5):856-62. doi: 10.1016/j.clinimag.2015.05.006.

PMID:
26091745
4.

[Diagnosis value of 3.0 T diffusion-weighted imaging with background suppression magnetic resonance for metastatic lymph nodes in rectal cancer].

Zhuang XZ, Yu SP, Cui J, Chen CQ, Zhao XJ, Pan BT, Li ZP.

Zhonghua Wei Chang Wai Ke Za Zhi. 2011 Nov;14(11):842-5. Chinese.

PMID:
22116716
5.

Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer.

Yasui O, Sato M, Kamada A.

Tohoku J Exp Med. 2009 Jul;218(3):177-83.

6.

Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.

Vandecaveye V, De Keyzer F, Vander Poorten V, Dirix P, Verbeken E, Nuyts S, Hermans R.

Radiology. 2009 Apr;251(1):134-46. doi: 10.1148/radiol.2511080128.

PMID:
19251938
7.
8.

Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.

Luo N, Su D, Jin G, Liu L, Zhu X, Xie D, Liu Y.

J Magn Reson Imaging. 2013 Oct;38(4):824-8. doi: 10.1002/jmri.24031.

PMID:
23440958
9.

Apparent diffusion coefficient for discriminating metastatic from non-metastatic lymph nodes in primary rectal cancer.

Cho EY, Kim SH, Yoon JH, Lee Y, Lim YJ, Kim SJ, Baek HJ, Eun CK.

Eur J Radiol. 2013 Nov;82(11):e662-8. doi: 10.1016/j.ejrad.2013.08.007.

PMID:
24016824
10.

Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes.

Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J.

Eur J Radiol. 2009 Dec;72(3):381-7. doi: 10.1016/j.ejrad.2008.09.034.

PMID:
18995981
11.

Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.

Chung J, Youk JH, Kim JA, Gweon HM, Kim EK, Ryu YH, Son EJ.

Acta Radiol. 2014 Oct;55(8):909-16. doi: 10.1177/0284185113509094.

PMID:
24234236
12.

Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT.

Vag T, Heck MM, Beer AJ, Souvatzoglou M, Weirich G, Holzapfel K, Rummeny EJ, Schwaiger M, Krause BJ, Eiber M.

Eur Radiol. 2014 Aug;24(8):1821-6. doi: 10.1007/s00330-014-3240-8. Erratum in: Eur Radiol. 2014 Aug;24(8):1827.

PMID:
24889997
13.

[Clinical significance of diffusion-weighted MRI with STIR-EPI in differential diagnosis of cervical lymph nodes].

Zhang Y, Liang BL, Gao L, Zhong JL, Ye RX, Shen J.

Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):70-3. Chinese.

PMID:
17575700
14.
15.

Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: a pilot study.

Si J, Huang S, Shi H, Liu Z, Hu Q, Wang G, Shen G, Zhang D.

Dentomaxillofac Radiol. 2014;43(3):20130202. doi: 10.1259/dmfr.20130202.

16.

Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.

Fornasa F, Nesoti MV, Bovo C, Bonavina MG.

J Magn Reson Imaging. 2012 Oct;36(4):858-64. doi: 10.1002/jmri.23706.

PMID:
22648570
17.

Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience.

Kim JK, Kim KA, Park BW, Kim N, Cho KS.

J Magn Reson Imaging. 2008 Sep;28(3):714-9. doi: 10.1002/jmri.21480. Erratum in: J Magn Reson Imaging. 2009 May;29(5):1242.

PMID:
18777531
18.

Role of diffusion-weighted MR imaging in cervical lymphadenopathy.

Abdel Razek AA, Soliman NY, Elkhamary S, Alsharaway MK, Tawfik A.

Eur Radiol. 2006 Jul;16(7):1468-77.

PMID:
16557366
19.

Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer.

Sumi M, Sakihama N, Sumi T, Morikawa M, Uetani M, Kabasawa H, Shigeno K, Hayashi K, Takahashi H, Nakamura T.

AJNR Am J Neuroradiol. 2003 Sep;24(8):1627-34.

20.

Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?

Heijnen LA, Lambregts DM, Martens MH, Maas M, Bakers FC, Cappendijk VC, Oliveira P, Lammering G, Riedl RG, Beets GL, Beets-Tan RG.

Eur Radiol. 2014 Feb;24(2):371-9. doi: 10.1007/s00330-013-3016-6.

PMID:
24051676
Items per page

Supplemental Content

Support Center